Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    NCT01397799
Previous Study | Return to List | Next Study

Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Kinex Pharmaceuticals Inc
ClinicalTrials.gov Identifier:
NCT01397799
First received: July 18, 2011
Last updated: December 4, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2014
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)